This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dalerba P, Cho RW, Clarke MF . Cancer stem cells: models and concepts. Annu Rev Med 2007; 58: 267–284.
Hope KJ, Jim L, Dick JE . Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004; 5: 738–743.
Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A . Tumor growth need not be driven by rare cancer stem cells. Science 2007; 317: 337.
Kodama S, Davis M, Faustman DL . Diabetes and stem cell researchers turn to the lowly spleen. Science SAGE 2005; 2005: pe2.
Raju K, Tang S, Dube ID, Kamel-Reid S, Bryce DM, Breitman ML . Characterization and developmental expression of Tlx-1, the murine homolog of HOX11. Mech Dev 1993; 44: 51–64.
Dear TN, Colledge WH, Carlton MB, Lavenir I, Larson T, Smith AJ et al. The Hox11 gene is essential for cell survival during spleen development. Development 1995; 121: 2909–2915.
Watt PM, Hoffmann K, Greene WK, Brake RL, Ford J, Kees UR . Specific alternative HOX11 transcripts are expressed in paediatric neural tumours and T-cell acute lymphoblastic leukaemia. GENE 2003; 323: 89–99.
Keller G, Wall C, Fong AZ, Hawley TS, Hawley RG . Overexpression of HOX11 leads to immortalization of embryonic precursors with both primitive and definitive hematopoeitic potential. Blood 1998; 92: 877–887.
Acknowledgements
The Iacocca Foundation sponsored the funding for this report. The donation and retrieval of human spleens was made possible through the resources of the Human Data Biological Interchange. Dr Francisco Dieguez was supported in party by the NIH Endocrine Training Grant No. DK007028.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dieguez-Acuna, F., Gygi, S., Davis, M. et al. Splenectomy: a new treatment option for ALL tumors expressing Hox-11 and a means to test the stem cell hypothesis of cancer in humans. Leukemia 21, 2192–2194 (2007). https://doi.org/10.1038/sj.leu.2404927
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404927
This article is cited by
-
Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo
Journal of Huazhong University of Science and Technology [Medical Sciences] (2016)
-
Fetal Hox11 expression patterns predict defective target organs: a novel link between developmental biology and autoimmunity
Immunology & Cell Biology (2008)